Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Fatty liver index"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
Diabetes Metab J. 2013;37(4):278-285.   Published online August 14, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.4.278
  • 4,885 View
  • 49 Download
  • 59 Crossref
AbstractAbstract PDFPubReader   
Background

Nonalcoholic fatty liver disease (NAFLD) is closely correlated with abnormal accumulation of visceral fat, but the role of skeletal muscle remains unclear. The aim of this study was to elucidate the role of skeletal muscle in development of NAFLD.

Methods

Among 11,116 subjects (6,242 males), we examined the effects of skeletal muscle mass and visceral fat area (VFA, by bioelectric impedance analysis) on NAFLD using by the fatty liver index (FLI).

Results

Of the total subjects (9,565 total, 5,293 males) included, 1,848 were classified as having NALFD (FLI ≥60). Body mass index, lipid profile, fasting plasma glucose, hemoglobin A1c, prevalence of type 2 diabetes (DM), hypertension (HTN), and metabolic syndrome were higher in males than females, but FLI showed no significant difference. The low FLI group showed the lowest VFA and highest skeletal muscle mass of all the groups. Skeletal muscle to visceral fat ratio (SVR) and skeletal muscle index had inverse correlations with FLI, when adjusted for age and gender. In multivariate regression analysis, SVR was negatively associated with FLI. Among SVR quartiles, the highest quartile showed very low risk of NAFLD when adjusted for age, gender, lipid profile, DM, HTN, and high sensitivity C-reactive protein from the lowest quartiles (odds ratio, 0.037; 95% confidence interval, 0.029 to 0.049).

Conclusion

Skeletal muscle mass was inversely associated with visceral fat area, and higher skeletal muscle mass may have a beneficial effect in preventing NAFLD. These results suggest that further studies are needed to ameliorate or slow the progression of sarcopenia.

Citations

Citations to this article as recorded by  
  • Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
    Jiaqin Yuan, Jinglin Zhang, Qiang Luo, Lipeng Peng
    Scientific Reports.2024;[Epub]     CrossRef
  • Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study
    Maha Hoteit, Myriam Dagher, Nikolaos Tzenios, Najat Al Kaaki, Ghadir Rkein, Abdul Rahman Chahine, Yonna Sacre, Samer Hotayt, Rami Matar, Mahmoud Hallal, Micheal Maitar, Bilal Hotayt
    Healthcare.2024; 12(5): 591.     CrossRef
  • Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population
    Chenbing Liu, Nan Li, Di Sheng, Yahong Shao, Lihong Qiu, Chao Shen, Zhong Liu
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study
    Da-Hye Son, Yu-Jin Kwon, Jun-Hyuk Lee
    The Journal of nutrition, health and aging.2024; 28(6): 100270.     CrossRef
  • Using hyperhomocysteinemia and body composition to predict the risk of non-alcoholic fatty liver disease in healthcare workers
    Xiaoyan Hao, Honghai He, Liyuan Tao, Peng Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diagnostic Criteria and Prognostic Relevance of Sarcopenia in Patients with Inflammatory Bowel Disease—A Systematic Review
    Claudia-Gabriela Potcovaru, Petruța Violeta Filip, Oana-Maria Neagu, Laura Sorina Diaconu, Teodor Salmen, Delia Cinteză, Anca Pantea Stoian, Florin Bobirca, Mihai Berteanu, Corina Pop
    Journal of Clinical Medicine.2023; 12(14): 4713.     CrossRef
  • Association between Muscle Mass Deficits and Metabolic Dysfunction-Associated Fatty Liver Disease in Adults with Body Mass Index Less than 23 kg/m2
    Mi Young Lee, Hee Jeong Choi, Han Jin Oh
    Korean Journal of Family Practice.2023; 13(3): 171.     CrossRef
  • Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease
    Gang Li, Rafael S. Rios, Xin-Xin Wang, Yue Yu, Kenneth I. Zheng, Ou-Yang Huang, Liang-Jie Tang, Hong-Lei Ma, Yi Jin, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng
    British Journal of Nutrition.2022; 127(11): 1613.     CrossRef
  • 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
    Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui,
    Clinical Gastroenterology and Hepatology.2022; 20(12): 2809.     CrossRef
  • Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
    Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani
    Biomedicines.2022; 10(1): 182.     CrossRef
  • Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
    Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Fatty Liver Index and Skeletal Muscle Density
    Julie A. Pasco, Sophia X. Sui, Emma C. West, Kara B. Anderson, Pamela Rufus-Membere, Monica C. Tembo, Natalie K. Hyde, Lana J. Williams, Zoe S. J. Liu, Mark A. Kotowicz
    Calcified Tissue International.2022; 110(6): 649.     CrossRef
  • Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun‐Suk Jung, Chan‐won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne
    Hepatology Communications.2022; 6(9): 2238.     CrossRef
  • Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
    Jun-Hyeon Byeon, Min-Kyu Kang, Min-Cheol Kim
    Healthcare.2022; 10(5): 850.     CrossRef
  • Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease
    Phunchai Charatcharoenwitthaya, Khemajira Karaketklang, Wichai Aekplakorn
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(5): 2393.     CrossRef
  • Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial
    Christine L Freer, Elena S George, Sze-Yen Tan, Gavin Abbott, David W Dunstan, Robin M Daly
    BMJ Open Diabetes Research & Care.2022; 10(5): e002950.     CrossRef
  • Muscle Krüppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis
    Liyan Fan, David R. Sweet, Domenick A. Prosdocimo, Vinesh Vinayachandran, Ernest R. Chan, Rongli Zhang, Olga Ilkayeva, Yuan Lu, Komal S. Keerthy, Chloe E. Booth, Christopher B. Newgard, Mukesh K. Jain
    Journal of Clinical Investigation.2021;[Epub]     CrossRef
  • “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
    David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still
    Obesity Science & Practice.2021; 7(5): 629.     CrossRef
  • Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs
    Kai Ushio, Yukio Mikami, Hiromune Obayashi, Hironori Fujishita, Kouki Fukuhara, Tetsuhiko Sakamitsu, Kazuhiko Hirata, Yasunari Ikuta, Hiroaki Kimura, Nobuo Adachi
    Journal of Clinical Medicine.2021; 10(11): 2272.     CrossRef
  • Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
    Min-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, Won-Young Tak, Se-Young Jang, Yu-Rim Lee, Keun Hur, Gyeonghwa Kim, Hye-Won Lee, Man-Hoon Han, Joon-Hyuk Choi, Soo-Young Park, Jung-Gil Park
    Diagnostics.2021; 11(6): 1061.     CrossRef
  • Association of Body Composition and Sarcopenia with NASH in Obese Patients
    Sophia Marie-Therese Schmitz, Lena Schooren, Andreas Kroh, Alexander Koch, Christine Stier, Ulf Peter Neumann, Tom Florian Ulmer, Patrick Hamid Alizai
    Journal of Clinical Medicine.2021; 10(15): 3445.     CrossRef
  • Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation
    Do Hyeon Pyun, Tae Jin Kim, Seung Yeon Park, Hyun Jung Lee, A.M. Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung
    Molecular and Cellular Endocrinology.2021; 538: 111464.     CrossRef
  • Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk
    Kenneth Pasmans, Michiel E. Adriaens, Peter Olinga, Ramon Langen, Sander S. Rensen, Frank G. Schaap, Steven W. M. Olde Damink, Florian Caiment, Luc J. C. van Loon, Ellen E. Blaak, Ruth C. R. Meex
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
    Iasmin dos Santos Barreto, Raquel Oliveira dos Santos, Raquel Rocha, Claudineia de Souza, Naiade Almeida, Luiza Valois Vieira, Rafael Leiróz, Manoel Sarno, Carla Daltro, Helma Pinchemel Cotrim
    Revista da Associação Médica Brasileira.2021; 67(9): 1233.     CrossRef
  • A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
    Kazuhiro Kashiwagi, Michiyo Takayama, Kayoko Fukuhara, Ryoko Shimizu-Hirota, Po-Sung Chu, Nobuhiro Nakamoto, Nagamu Inoue, Yasushi Iwao, Takanori Kanai
    Clinical Nutrition ESPEN.2020; 38: 86.     CrossRef
  • Improvement in Menopause-Associated Hepatic Lipid Metabolic Disorders by Herbal Formula HPC03 on Ovariectomized Rats
    BoYoon Chang, Dae Sung Kim, SungYeon Kim
    Evidence-Based Complementary and Alternative Medicine.2020; 2020: 1.     CrossRef
  • Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
    D.H. Seo, Y.-h. Lee, S.W. Park, Y.J. Choi, B.W. Huh, E. Lee, K.B. Huh, S.H. Kim, B.-S. Cha
    Diabetes & Metabolism.2020; 46(5): 362.     CrossRef
  • Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications
    Tiziana Fernández-Mincone, Felipe Contreras-Briceño, Maximiliano Espinosa-Ramírez, Patricio García-Valdés, Antonio López-Fuenzalida, Arnoldo Riquelme, Juan Pablo Arab, Daniel Cabrera, Marco Arrese, Francisco Barrera
    Expert Review of Gastroenterology & Hepatology.2020; 14(12): 1141.     CrossRef
  • Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
    Min Kyu Kang, Jung Gil Park, Min Cheol Kim
    Yonsei Medical Journal.2020; 61(10): 860.     CrossRef
  • Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease
    Hwi Young Kim, Su Jung Baik, Hye Ah Lee, Byoung Kwon Lee, Hye Sun Lee, Tae Hun Kim, Kwon Yoo
    Scientific Reports.2020;[Epub]     CrossRef
  • Fisetin Alleviates Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice
    Myung-Sook Choi, Ji-Young Choi, Eun-Young Kwon
    Journal of Medicinal Food.2020; 23(10): 1019.     CrossRef
  • Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
    Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu
    Hepatology International.2020; 14(1): 115.     CrossRef
  • Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
    Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
    Digestive Diseases.2020; 38(6): 507.     CrossRef
  • Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women
    Yajie Zhang, Dajiang Lu, Renwei Wang, Weijie Fu, Shengnian Zhang
    Medicina.2019; 55(10): 629.     CrossRef
  • Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study
    Beom-Jun Kim, Seong Hee Ahn, Seung Hun Lee, Seongbin Hong, Mark W. Hamrick, Carlos M. Isales, Jung-Min Koh
    Aging.2019; 11(13): 4547.     CrossRef
  • Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics
    Debbie S Thompson, Ingrid A Tennant, Deanne P Soares, Clive Osmond, Chris D Byrne, Terrence E Forrester, Michael S Boyne
    Journal of the Endocrine Society.2019; 3(11): 2051.     CrossRef
  • Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?
    C. H. De Fré, M. A. De Fré, W. J. Kwanten, B. J. Op de Beeck, L. F. Van Gaal, S. M. Francque
    Obesity Reviews.2019; 20(2): 353.     CrossRef
  • Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
    Louise Johanna Maria Alferink, Katerina Trajanoska, Nicole Stephanie Erler, Josje Dorothea Schoufour, Robert Jacobus de Knegt, M. Arfan Ikram, Harry Leonardus Antonius Janssen, Oscar H. Franco, Herold J. Metselaar, Fernando Rivadeneira, Sarwa Darwish Mura
    Journal of Bone and Mineral Research.2019; 34(7): 1254.     CrossRef
  • Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
    Goh Eun Chung, Min Joo Kim, Jeong Yoon Yim, Joo Sung Kim, Ji Won Yoon
    Journal of Obesity & Metabolic Syndrome.2019; 28(2): 129.     CrossRef
  • Association of low skeletal muscle mass with advanced liver fibrosis in patients with non‐alcoholic fatty liver disease
    Min Kyu Kang, Jung Gil Park, Heon Ju Lee, Min Cheol Kim
    Journal of Gastroenterology and Hepatology.2019; 34(9): 1633.     CrossRef
  • Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study
    Sechang Oh, Natsumi Oshida, Noriko Someya, Tsuyoshi Maruyama, Tomonori Isobe, Yoshikazu Okamoto, Taeho Kim, Bokun Kim, Junichi Shoda
    Physiological Reports.2019; 7(9): e14062.     CrossRef
  • L-Lysine Attenuates Hepatic Steatosis in Senescence-Accelerated Mouse Prone 8 Mice
    Tomonori SATO, Nao MURAMATSU, Yoshiaki ITO, Yoshio YAMAMOTO, Takashi NAGASAWA
    Journal of Nutritional Science and Vitaminology.2018; 64(3): 192.     CrossRef
  • Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice
    Alexandre Abilio de Souza Teixeira, Camila O. Souza, Luana A. Biondo, Loreana Sanches Silveira, Edson A. Lima, Helena A. Batatinha, Adriane Pereira Araujo, Michele Joana Alves, Sandro Massao Hirabara, Rui Curi, José Cesar Rosa Neto
    Inflammopharmacology.2018; 26(4): 1103.     CrossRef
  • Vitamin D and Related Deficiencies, Sarcopenia and Visceral Obesity in Obese People with NAFLD
    Mihaela Petrova
    Gastroenterology & Hepatology: Open Access.2018;[Epub]     CrossRef
  • Grip Strength Moderates the Association between Anthropometric and Body Composition Indicators and Liver Fat in Youth with an Excess of Adiposity
    Robinson Ramírez-Vélez, Mikel Izquierdo, Jorge Correa-Bautista, Alejandra Tordecilla-Sanders, María Correa-Rodríguez, Jacqueline Schmidt Rio-Valle, Emilio González-Jiménez, Katherine González-Ruíz
    Journal of Clinical Medicine.2018; 7(10): 347.     CrossRef
  • Longitudinal Changes in Muscle Mass and Strength, and Bone Mass in Older Adults: Gender-Specific Associations Between Muscle and Bone Losses
    Kyoung Min Kim, Soo Lim, Tae Jung Oh, Jae Hoon Moon, Sung Hee Choi, Jae Young Lim, Ki Woong Kim, Kyong Soo Park, Hak Chul Jang
    The Journals of Gerontology: Series A.2018; 73(8): 1062.     CrossRef
  • Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle
    Eleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Claudio Chiesa, Lucia Pacifico
    World Journal of Gastroenterology.2017; 23(10): 1747.     CrossRef
  • Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
    Cristiane V Tovo, Sabrina A Fernandes, Caroline Buss, Angelo A de Mattos
    World Journal of Hepatology.2017; 9(6): 326.     CrossRef
  • Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease
    Chunxia Wang, Robert Batey, Johji Yamahara, Yuhao Li
    Journal of Functional Foods.2017; 36: 43.     CrossRef
  • Importance of Lean Muscle Maintenance to Improve Insulin Resistance by Body Weight Reduction in Female Patients with Obesity
    Yaeko Fukushima, Satoshi Kurose, Hiromi Shinno, Ha Cao Thu, Nana Takao, Hiromi Tsutsumi, Yutaka Kimura
    Diabetes & Metabolism Journal.2016; 40(2): 147.     CrossRef
  • Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
    Eleonora Poggiogalle, Carla Lubrano, Lucio Gnessi, Stefania Mariani, Andrea Lenzi, Lorenzo Maria Donini, Rasheed Ahmad
    PLOS ONE.2016; 11(1): e0145811.     CrossRef
  • The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes
    Yoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, Muhei Tanaka, Masahiro Yamazaki, Michiaki Fukui
    Endocrine Journal.2016; 63(10): 877.     CrossRef
  • Sarcopenia and the cardiometabolic syndrome: A narrative review
    G. Bahat, B. İlhan
    European Geriatric Medicine.2016; 7(3): 220.     CrossRef
  • Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey
    Hee Yeon Kim, Chang Wook Kim, Chung-Hwa Park, Jong Young Choi, Kyungdo Han, Anwar T Merchant, Yong-Moon Park
    Hepatobiliary & Pancreatic Diseases International.2016; 15(1): 39.     CrossRef
  • Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
    Sven M. Francque, Denise van der Graaff, Wilhelmus J. Kwanten
    Journal of Hepatology.2016; 65(2): 425.     CrossRef
  • Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia
    Kyoung Min Kim, Hak Chul Jang, Soo Lim
    The Korean Journal of Internal Medicine.2016; 31(4): 643.     CrossRef
  • Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population
    Ge Meng, Hongmei Wu, Liyun Fang, Chunlei Li, Fei Yu, Qing Zhang, Li Liu, Huanmin Du, Hongbin Shi, Yang Xia, Xiaoyan Guo, Xing Liu, Xue Bao, Qian Su, Yeqing Gu, Huijun Yang, Bin Yu, Yuntang Wu, Zhong Sun, Kaijun Niu
    Scientific Reports.2016;[Epub]     CrossRef
  • Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES)
    Stefano Balducci, Patrizia Cardelli, Luca Pugliese, Valeria D’Errico, Jonida Haxhi, Elena Alessi, Carla Iacobini, Stefano Menini, Lucilla Bollanti, Francesco G. Conti, Antonio Nicolucci, Giuseppe Pugliese
    Diabetes Research and Clinical Practice.2015; 109(2): 355.     CrossRef
  • Sarcopenia is a risk factor for elevated aminotransferase in men independently of body mass index, dietary habits, and physical activity
    Ki Deok Yoo, Dae Won Jun, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Byung Chul Yoon, Ho Soon Choi
    Digestive and Liver Disease.2015; 47(4): 303.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer